Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) ; volume:149 ; number:13 ; day:5 ; month:7 ; year:2023 ; pages:11705-11718 ; date:10.2023
Journal of cancer research and clinical oncology ; 149, Heft 13 (5.7.2023), 11705-11718, 10.2023
- Creator
-
Kähler, Katharina C.
Hüning, S.
Nashan, D.
Meiß, Frank
Rafei-Shamsabadi, D. A.
Rissmann, H.
Colapietro, C.
Livingstone, E.
Maul, L. V.
Heppt, M.
Hassel, Jessica C.
Gutzmer, Ralf
Loquai, C.
Heinzerling, Lucie
Sachse, M. M.
Bohne, A. S.
Moysig, L.
Peters, W.
Rusch, J.
Blome, Christine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-023-05027-z
- URN
-
urn:nbn:de:101:1-2023110712083314298378
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kähler, Katharina C.
- Hüning, S.
- Nashan, D.
- Meiß, Frank
- Rafei-Shamsabadi, D. A.
- Rissmann, H.
- Colapietro, C.
- Livingstone, E.
- Maul, L. V.
- Heppt, M.
- Hassel, Jessica C.
- Gutzmer, Ralf
- Loquai, C.
- Heinzerling, Lucie
- Sachse, M. M.
- Bohne, A. S.
- Moysig, L.
- Peters, W.
- Rusch, J.
- Blome, Christine
- SpringerLink (Online service)
Other Objects (12)
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Melanoma risk loci as determinants of melanoma recurrence and survival
Adjuvant and neoadjuvant treatment of melanoma
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Recurrence of Melanoma after Starting Apremilast for Psoriasis
Adjuvant radiation therapy in metastatic lymph nodes from melanoma
Late Recurrence of Malignant Choroidal Melanoma Mimicking Hepatocellular Carcinoma
Serum microRNAs as biomarkers for recurrence in melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Societal preferences for adjuvant melanoma health states: UK and Australia
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Melanoma risk loci as determinants of melanoma recurrence and survival
Adjuvant and neoadjuvant treatment of melanoma
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Recurrence of Melanoma after Starting Apremilast for Psoriasis
Adjuvant radiation therapy in metastatic lymph nodes from melanoma
Late Recurrence of Malignant Choroidal Melanoma Mimicking Hepatocellular Carcinoma
Serum microRNAs as biomarkers for recurrence in melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Societal preferences for adjuvant melanoma health states: UK and Australia
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Melanoma risk loci as determinants of melanoma recurrence and survival
Adjuvant and neoadjuvant treatment of melanoma
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Recurrence of Melanoma after Starting Apremilast for Psoriasis
Adjuvant radiation therapy in metastatic lymph nodes from melanoma
Late Recurrence of Malignant Choroidal Melanoma Mimicking Hepatocellular Carcinoma
Serum microRNAs as biomarkers for recurrence in melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade